CAMBRIDGE, Mass.--(BUSINESS WIRE)--Portal Instruments, a medical device company focused on advanced drug delivery and solving the challenge of self-administering biological medicines, is pleased to announce that Senior Director of Marketing Barbara Taylor will be speaking at the inaugural Drug Delivery West program in San Francisco, taking place May 21-22. The program explores how to reduce risk and advance drug delivery technologies for current and future needs.
Taylor will present “Needle-free Injectors, Innovative Drug Delivery to Differentiate your Brand“ on May 21 at 3pm. The presentation discusses Portal Instruments’ advancements in needle-free drug delivery using a highly innovative jet injection platform licensed from the Massachusetts Institute of Technology (MIT). The platform is designed for home-use self-administration to avoid the hassle and complication of traditional needles and has the potential for applications across a range of biologic medicines that currently require administration through an injection.
“Our aim is to replace all needles and syringes with a safe, fast, and connected device and to become the standard for modern drug delivery,” said Taylor. “The device Portal Instruments is commercializing is easy to use and its digital health features empower the patient to holistically manage their chronic condition interactively.”
More information about Portal Instruments can be found at www.portalinstruments.com.
Details on the Drug Delivery West program can be found at theconferenceforum.org/conferences/drug-delivery-west/overview/.
About Portal Instruments
Portal Instruments is a medical device company focused on advanced drug delivery and backed by strategic and venture investors. Portal Instruments is developing and commercializing a highly innovative needle-free drug delivery platform technology to transform the administration of medicines and improve the patient experience for chronic diseases. Real time tracking and reporting sets a new standard for interactivity between the patient and care teams, monitoring adherence and potentially improving patient outcomes. Portal Instruments’ Quality Management System is ISO 13485 certified. For more information, please visit www.portalinstruments.com or follow @portalcambridge on Twitter.